Connect with us

Health

Youth Influencers Educated On Covid 19 Vaccine Safety And Effectiveness, Urged To Encourage Vaccine Uptake

editor

Published

on

Friday Bako

As part of the COVID-19 awareness project, Friday Bako, the implementing partner with the Centre for Information Technology and Development (CITAD) and MacArthur Foundation has organized a town hall meeting with youth influencers on COVID-19 vaccine safety and effectiveness at Greatlinks Continental Hotel Hall Gold & Base, Plateau State on the 21st of December.

Presenting a paper on the subject matter the guest speaker Mr. Tobias Choji, Chief Medical Laboratory Scientist at National Veterinary Research Institute (NVRI) Vom in Plateau State, called on Stakeholders including Government, Civil Society Organizations, Non-Governmental organizations, Youth influencers, and citizens to play frontal roles in encouraging Covid-19 Vaccine Uptake so as to achieve herd immunity.

He said that the Covid-19 Vaccines had been certified safe globally because it has passed through the different stages of a clinical trial.

“The Covid-19 Vaccine has gone through all four clinical trial stages. Both the efficiency and effectiveness have been tested and approved by the World Health Organization (WHO)”.

“The covid-19 Vaccine was developed faster than other vaccines which took years to develop because it belongs to a family of viruses that already exist and technologies needed for the research already exist. Another reason is that every country shared their genetic information and findings about the virus, some of the stages of the clinical trial took place simultaneously, a lot of finance went into the development of the vaccine, information on social media also helped the development of the vaccine, and many organisations took the risk to start the mass production of the vaccine while waiting for authorization after which the where distributed”.

Mr. Tobias Choji, urged the Government to create an avenue for checking citizens that have taken the vaccine to ascertain those that have actually been immunized.  He encouraged the use of “Seroprevalence”, which is a system of checking the number of persons in a population who test positive for a specific disease based on serology specimens; often presented as a percent of the total specimens tested or as a proportion per 100,000 persons tested.

On Civil Society Organizations and Non-Governmental organizations, Mr. Tobias Choji, urged for more town hall meetings and avenues for citizens’ engagement to address lingering concerns and the dispelling of misinformation and fake news.

“Citizens must take their health seriously, and avoid taking information from unauthorized persons. When citizens also get information from town halls such as this, they should in turn be willing to sensitize their family members and immediate community.” He said

Choji added that any adverse event that one may experience after receiving the Covid-19 vaccine might not have a relationship with the vaccine as it can be as a result of a preexisting sickness in the system such as malaria.

Implementing Partner of CITAD/MacArthur Foundation COVID-19 Vaccine Public Awareness Project, Comrade Friday Bako in his address said the objective of the town hall meeting is to get influencers who will learn about the Covid-19 Vaccine safety and effectiveness after which they can also create public awareness in there various communties.

“The program has been on for almost a year now and so far  the  town halls have yielded positive results as this is the fifth town hall meeting in the series covering all the senatorial zones in Plateau state. We have seen an increase in the uptake of the vaccine as a result of several engagements held as such the need for more advocacy”

The highlight of the meeting witnessed participants assenting to become implementing partners and ambassadors for correcting some of the wrong perceptions that are contributing to the slow uptake of the covid-19 vaccines in their communities.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

PT HEALTH WATCH: What pregnant women should know about bloating, warning signs

info

Published

on

Pregnant belly e1597321301617.jpg

Bloating, a feeling of fullness or swelling in the abdomen, is common during pregnancy because hormonal changes slow digestion, increasing the likelihood of gas and constipation.

Although often harmless, persistent or unusual abdominal discomfort, particularly when accompanied by severe pain, vomiting, fever or vaginal bleeding, may indicate a condition requiring medical attention.

To explain the causes, management and warning signs of pregnancy-related bloating, PREMIUM TIMES spoke with Halimat Jimoh, a midwife, who also cautioned against self-medication.

Why bloating occurs during pregnancy

Ms Jimoh said bloating could occur at any stage of pregnancy, although some women experience it more during the first trimester because of hormonal changes.

She explained that increased progesterone levels relax the muscles of the digestive tract, slowing the movement of food through the intestines. This can cause gas accumulation, constipation and abdominal discomfort.

As pregnancy advances, the growing uterus may also put pressure on digestive organs.

PT WHATSAPP CHANNEL
Dangote Refinery AD

According to her, pregnancy-related bloating is generally mild, may come and go, and can improve after passing gas or having a bowel movement.

However, she advised women not to assume that every episode of abdominal discomfort is a normal pregnancy symptom.

Warning signs women should not ignore

Ms Jimoh said severe or persistent abdominal pain, repeated vomiting, fever and vaginal bleeding should prompt medical assessment.

She noted that conditions such as gastrointestinal infections, appendicitis, gallbladder problems and intestinal obstruction could cause abdominal discomfort and swelling.

Severe upper abdominal pain, particularly on the right side, accompanied by a severe headache, changes in vision or sudden swelling of the face and hands, could indicate pre-eclampsia, a potentially serious pregnancy complication.

Other warning signs include difficulty breathing, fainting and a significant deterioration in the woman’s general condition.

She also advised women to seek immediate assessment if they notice reduced or absent fetal movements after their baby’s movements have become established.

Managing bloating safely

According to Ms Jimoh, fizzy drinks, beans and other gas-producing foods may worsen bloating in some women, while large meals and very fatty foods may increase digestive discomfort.

She recommended eating smaller, more frequent meals, eating slowly and drinking enough water. Gentle physical activity, such as walking, may also support digestion and relieve constipation.

For women experiencing constipation, she advised increasing fibre intake through fruits, vegetables and whole grains, while ensuring adequate fluid consumption.

However, she encouraged women to identify their individual food triggers rather than unnecessarily eliminating entire food groups from their diets.

Dangers of self-medication

Ms Jimoh warned against taking medicines or herbal preparations for bloating without consulting a qualified healthcare professional.

She explained that over-the-counter medicines are not automatically safe during pregnancy, as their suitability may depend on the stage of pregnancy and the woman’s individual circumstances.

She added that products described as natural are not necessarily safe, particularly when their ingredients have not been adequately studied in pregnancy or may interact with other medicines.

The midwife advised women to disclose their stage of pregnancy, medications and supplements to their healthcare providers before taking anything for persistent bloating or constipation.

She also cautioned that self-medication could mask symptoms of an underlying condition requiring treatment.

When to seek medical care

Ms Jimoh urged pregnant women to seek urgent medical attention when bloating occurs alongside severe or persistent abdominal pain, repeated vomiting, vaginal bleeding, fever, fainting or difficulty breathing.

READ ALSO: PT Health Watch: How Pregnancy-Induced Hypertension puts mother, baby at risk

Sudden swelling of the face or hands, severe headache, visual disturbances and severe upper abdominal pain also require prompt assessment because they may indicate pre-eclampsia.

She reiterated that reduced or absent fetal movements warrant immediate assessment.

According to her, persistent, severe or unusual symptoms should be investigated rather than simply treated as digestive discomfort.

She encouraged women to seek professional advice whenever they are unsure whether a symptom is normal, stressing that timely assessment can help identify complications and prevent delays in care.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Health

Ebola: Kenya records third case, continues contact tracing

info

Published

on

Liberia ebola.jpg

Kenya has confirmed a third case of Ebola after a 65-year-old woman tested positive while in quarantine.

The woman is a close relative of Kenya’s first confirmed patient, a 40-year-old who died from Ebola on 5 October, two days after arriving in Kenya from the Democratic Republic of the Congo (DRC).

The Associated Press (AP) reported that the woman had been in quarantine since 6 October and developed symptoms before testing positive. She has since been transferred to an infectious disease unit for treatment.

The second patient, a 39-year-old man from the same family, remains stable, according to Kenya’s Ministry of Health.

The ministry said there was no evidence of community transmission, as all three cases were linked to the first patient and the individuals had been in quarantine.

Nigeria’s preparedness

The development comes as Nigeria continues to monitor the regional outbreak and strengthen preparedness against possible importation of the virus.

PT WHATSAPP CHANNEL
Dangote Refinery AD

PREMIUM TIMES reported on 7 October that the Nigeria Centre for Disease Control and Prevention (NCDC) was reviewing the country’s preparedness after Kenya confirmed its first imported case of the Bundibugyo strain of Ebola.

In a statement issued on 6 October, the NCDC said the case highlighted the risk of international importation through travel and population movement, including the possibility of the virus entering Nigeria.

The agency said it was working with the Federal Ministry of Health and Social Welfare, Port Health Services, state governments and other partners to strengthen surveillance, early detection, laboratory diagnosis, isolation, contact tracing and infection prevention.

It also said Nigeria conducted a national Ebola preparedness simulation exercise to assess its readiness to respond to a possible case.

As of 6 October, the NCDC said Nigeria had no confirmed Ebola case.

Contact tracing continues

Kenya’s first case involved a 40-year-old man who had been living in the DRC and travelled through Uganda before arriving in Nairobi. He tested positive for Ebola and died on 5 October.

The confirmation of a second case on 14 October raised concerns about further infections among people exposed to the initial patient.

PREMIUM TIMES reported on 14 October that the second patient, a 39-year-old close relative of the first case, developed symptoms while in quarantine.

At the time, Kenyan authorities had identified 128 contacts linked to the first patient, with 113 located and efforts ongoing to trace the remaining 15.

In its report on Friday, AP said three contacts of the initial patient remained unaccounted for, while authorities continued efforts to trace people who might have been exposed.

The latest case brings the number of confirmed Ebola infections in Kenya to three. 

Regional outbreak

The cases in Kenya are linked to the ongoing Ebola outbreak in the DRC, where the Bundibugyo virus has caused thousands of infections and deaths.

The World Health Organisation (WHO) said the DRC had recorded 7,890 confirmed cases and 3,799 deaths as of 23 September.

The outbreak has raised concerns about cross-border transmission, particularly as people travel between affected areas and neighbouring countries.

The Bundibugyo virus is a distinct species of Ebola virus. No vaccine or treatment has been specifically approved for this strain.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending